Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of a Transfusion Therapy Using Whole Blood Versus Fractionated Blood Products in the Management of Coagulopathy in Patients Admitted to Hospital for Acute Traumatic Hemorrhage

NCT04431999 is registered in ClinicalTrials.gov with Direction Centrale du Service de Santé des Armées as lead sponsor.

NCT NCT04431999
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04431999 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of a Transfusion Therapy Using Whole Blood Versus Fractionated Blood Products in the Management of Coagulopathy in Patients Admitted to Hospital for Acute Traumatic Hemorrhage
Lead sponsor
Direction Centrale du Service de Santé des Armées
Phase
Phase 3
Overall status
Completed
Start date
December 4, 2021
Completion date
October 20, 2025
Enrollment
200 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

acute hemorrhage, coagulopathy, trauma